Low blood pressure, or hypotension, is linked to a significantly higher risk of developing Alzheimer’s disease, according to a study published in the Journal of the American Heart Association. Researchers analyzing data from nearly 800,000 adults found that individuals with low blood pressure were up to three times more likely to be diagnosed with Alzheimer’s … Read more
Americans with the highest levels of obesity are undergoing fewer surgical procedures, despite a rising national prevalence of severe obesity. A study published in the journal Obesity, which analyzed 11.6 million surgical cases between 2005 and 2022, found that patients with higher body mass index (BMI) levels are increasingly underrepresented in surgical care for common … Read more
The American Heart Association and the American College of Cardiology have introduced the first clinical practice guideline for cardiovascular-kidney-metabolic (CKM) syndrome, a framework designed to identify and manage the interconnected risks of heart, kidney, and metabolic diseases. Nearly 90% of U.S. adults possess at least one risk factor for the condition, such as obesity, high … Read more
The Albert Einstein College of Medicine has launched the Batia and Idan Ofer program for Validation of Interventions Targeting Aging and Longevity (BIO-VITAL), a specialized initiative designed to accelerate the development of pharmaceutical therapies that address the biological mechanisms of aging. By providing biotechnology firms access to proprietary research models and human longevity data, the … Read more
Between 1990 and 2024, 64 countries implemented sugar-sweetened beverage (SSB) taxes, affecting roughly 3.5 billion people worldwide. According to a study published June 8, 2026, in The Lancet Global Health, these policy shifts are primarily driven by a nation’s existing burdens of obesity and type 2 diabetes rather than current rates of sugary drink consumption. … Read more
New research published in Nature Medicine reveals that the medication dapagliflozin significantly reduces the risk of heart failure in patients who carry specific cardiomyopathy-associated genetic variants. Findings from the Mass General Brigham Heart and Vascular Institute and the Broad Institute of MIT and Harvard suggest that these genetic markers could help clinicians identify patients who … Read more
Research published in the journal Annals of Oncology indicates that GLP-1 receptor agonists (GLP-1 RAs) are associated with a 41% reduction in overall cancer risk among obese, non-diabetic adults. This study of more than 229,000 patients suggests these medications may offer significant benefits for cancer prevention beyond simple weight management. Which cancers are linked to … Read more
Infections represent a critical, under-recognized health hazard for people living with diabetes, according to a major study published in the journal Diabetes. Researchers from City St George’s, University of London found that patients across the diabetes spectrum face significantly higher risks of infection, hospitalization, and death compared to those without the condition, yet these risks … Read more
The landscape of American biomedical research is undergoing a seismic shift. As the National Institutes of Health (NIH) pivots toward the “Make America Healthy Again” (MAHA) agenda, the scientific community is finding itself at a crossroads between traditional research methodologies and a new, politically driven mandate for change. The MAHA Agenda: A New Direction for … Read more
Rethinking Blood Pressure Management in Diabetic Kidney Disease For millions of people living with type 2 diabetes (T2D), managing blood pressure is a critical, daily necessity. High blood pressure acts as a silent accelerator for diabetic kidney disease (DKD), a condition that gradually compromises the kidneys’ ability to filter waste from the blood. However, recent … Read more